Flugen, Inc. Cell-Based, Egg-Free Method Produces Novel 2009 H1N1 Vaccine Virus
MADISON, Wis.--(BUSINESS WIRE)--FluGen Inc., an emerging leader in the development, production and delivery of influenza vaccines, today announced that its proprietary CHO-cell-based production system has generated novel 2009 H1N1 influenza vaccine virus without the use of eggs during any step of production.